Patients Aged ≥65 Years with Metastatic Colon Cancer: Associations of Clinicopathological Factors, Skeletal Muscle Mass, and Inflammatory–Nutritional Indices with Survival

Objective: Prognostic assessment in older patients with metastatic colon cancer remains challenging. This study aimed to evaluate the associations of clinicopathological characteristics, computed tomography (CT)-defined low skeletal muscle mass, and inflammatory–nutritional indices with overall survival (OS) and progression-free survival (PFS). Methods: This single-center study analyzed data from 141 patients aged ≥65 years who received first-line systemic therapy between 2020 and 2026. Skeletal muscle index was evaluated in 128 patients using pretreatment CT images. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox proportional hazards regression analysis. Results: The median age was 71 years, and 75.0% of evaluable patients had a low skeletal muscle mass. The median OS was 30.32 months (95% confidence interval [CI]: 26.60–34.05), while the median PFS was 10.28 months (95% CI: 8.59–11.98). Synchronous metastases (hazard ratio [HR] = 3.745), Grade 3 tumors (HR = 3.084), absence of metastasectomy (HR = 3.650), high Köhne risk (HR = 2.546) and elevated carbonhydrate antigen [CA19-9] levels (HR = 1.812) were independently associated with shorter OS. Body mass index (BMI) of ≥25 kg/m2 was associated with a lower risk of mortality (HR = 0.624). High Köhne risk (HR = 2.162), Grade 3 tumors (HR = 1.750), elevated carcinoembryonic antigen [CEA] levels (HR = 1.716) and elevated CA19-9 levels (HR = 1.579) were independently associated with shorter PFS. No statistically significant difference was found between low skeletal muscle mass and survival. Furthermore, none of the inflammatory–nutritional indices included in the key multivariable models maintained their independent prognostic significance. Conclusions: High Köhne risk, poor tumor differentiation, and elevated CA19-9 levels were independently associated with shorter OS and PFS in older patients with metastatic colon cancer. There was no statistically significant difference between low skeletal muscle mass and survival outcomes, while inflammatory–nutritional indices did not show independent prognostic significance in the key multivariable models. Further prospective studies involving larger patient populations are needed to confirm these results.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-17
DOI
https://doi.org/10.3390/jcm15229020
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Patients Aged ≥65 Years with Metastatic Colon Cancer: Associations of Clinicopathological Factors, Skeletal Muscle Mass, and Inflammatory–Nutritional Indices with Survival

Aytül Hande Yardımcı, Murat Yakın, Gökmen Umut Erdem, Esma Yetim et al.
Journal of Clinical Medicine
Nutrition and Health in Aging
article

Patients Aged ≥65 Years with Metastatic Colon Cancer: Associations of Clinicopathological Factors, Skeletal Muscle Mass, and Inflammatory–Nutritional Indices with Survival

Aytül Hande Yardımcı, Murat Yakın, Gökmen Umut Erdem, Esma Yetim, Nilüfer Bulut, Faruk Aksu, Sevcan Genç, Zişan Hayriye Yücel
article en

Abstract

Objective: Prognostic assessment in older patients with metastatic colon cancer remains challenging. This study aimed to evaluate the associations of clinicopathological characteristics, computed tomography (CT)-defined low skeletal muscle mass, and inflammatory–nutritional indices with overall survival (OS) and progression-free survival (PFS). Methods: This single-center study analyzed data from 141 patients aged ≥65 years who received first-line systemic therapy between 2020 and 2026. Skeletal muscle index was evaluated in 128 patients using pretreatment CT images. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox proportional hazards regression analysis. Results: The median age was 71 years, and 75.0% of evaluable patients had a low skeletal muscle mass. The median OS was 30.32 months (95% confidence interval [CI]: 26.60–34.05), while the median PFS was 10.28 months (95% CI: 8.59–11.98). Synchronous metastases (hazard ratio [HR] = 3.745), Grade 3 tumors (HR = 3.084), absence of metastasectomy (HR = 3.650), high Köhne risk (HR = 2.546) and elevated carbonhydrate antigen [CA19-9] levels (HR = 1.812) were independently associated with shorter OS. Body mass index (BMI) of ≥25 kg/m2 was associated with a lower risk of mortality (HR = 0.624). High Köhne risk (HR = 2.162), Grade 3 tumors (HR = 1.750), elevated carcinoembryonic antigen [CEA] levels (HR = 1.716) and elevated CA19-9 levels (HR = 1.579) were independently associated with shorter PFS. No statistically significant difference was found between low skeletal muscle mass and survival. Furthermore, none of the inflammatory–nutritional indices included in the key multivariable models maintained their independent prognostic significance. Conclusions: High Köhne risk, poor tumor differentiation, and elevated CA19-9 levels were independently associated with shorter OS and PFS in older patients with metastatic colon cancer. There was no statistically significant difference between low skeletal muscle mass and survival outcomes, while inflammatory–nutritional indices did not show independent prognostic significance in the key multivariable models. Further prospective studies involving larger patient populations are needed to confirm these results.

Journal of Clinical MedicineVol. 15(22)
Sivas State Hospital (TR), Haseki Eğitim ve Araştırma Hastanesi (TR), İstanbul Başakşehir Çam ve Sakura Şehir Hastanesi (TR)
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon